Opioid Overdose Clinical Trial
— OPSOfficial title:
Evaluation of an Experimental Educational Module on Opioid-related Occupational Safety to Minimize Barriers toOverdose Response Among Police Officers
Verified date | March 2023 |
Source | New York University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Overdose deaths are currently the largest cause of accidental death in the US and opioid-related overdose deaths constitute the overwhelming majority of these deaths. Demands for a knowledge-base for effective law enforcement interventions is growing. This proposed study is designed to provide a knowledge base regarding key obstacles and facilitators of the willingness and preparedness of police to administer naloxone and related risk reduction practices and evaluate the efficacy of a web-based opioid-related occupational safety and risk reduction curriculum. Findings from this study will be applied to the development and implementation of effective interventions for police officers aimed at harmonizing law enforcement practices with public health goals.
Status | Active, not recruiting |
Enrollment | 333 |
Est. completion date | March 1, 2024 |
Est. primary completion date | February 10, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Active duty Police Officer Exclusion Criteria: - Desk only- not active duty |
Country | Name | City | State |
---|---|---|---|
United States | New York University | New York | New York |
Lead Sponsor | Collaborator |
---|---|
New York University | Centers for Disease Control and Prevention |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Degree of participant familiarity with fentanyl-class substances | Over your career, how often have you been exposed to touching or breathing in powder fentanyl?
A first responder's risk of experiencing an overdose from touching fentanyl is high A first responder's risk of experiencing an overdose from breathing fentanyl is high Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree) |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Degree of participant familiarity with best-practices related to policing PWUO and PWID who may be carrying heroin contaminated with fentanyl-class substances | I am confident that I won't overdose from incidental skin contact with fentanyl.
I am confident about my ability to use basic protective equipment to avoid fentanyl exposure Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Opioid-Related OD knowledge | The items related to a participant's ability to recognize and respond to an opioid-related overdose, with or without naloxone, were adapted from the Opioid Overdose Knowledge Scale (OOKS).
I am confident that I can effectively reverse an overdose using rescue techniques and naloxone I am confident that I can recognize an opioid overdose when I see it. I am confident that I know how to conduct myself at an overdose scene to safeguard public health and public safety Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Hypothesized Mediators of Intervention Efficacy: Stigma | Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree Providing naloxone to people with addiction enables more risky drug use Distributing naloxone widely in the community is a good way to reduce overdose fatalities Rapidly giving a lot of naloxone (blasting) when reversing an overdose is a good way to teach someone a lesson It is important to prevent overdose risk directly following a period of incarceration I worry about my safety when I encounter people with addiction People with addiction make communities less safe People with addiction can make positive health choices to protect themselves or others When people with addiction are placed in secure /mandated treatment facilities, communities are better off A lot of people with addiction are outsiders coming into communities to peddle drugs | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Potential Moderators: Demographic Variables | Age This construct will be assessed via the following item: What is your age (in years)?
Sex This construct will be assessed via the following multiple choice item: What is your gender? Law enforcement rank This construct will be assessed via the following multiple choice item: What is your current rank? Number of years on the job This construct will be assessed via the following item: What is the total number of years you have been working in law enforcement (including work in PA and other states, if relevant)? |
Baseline | |
Other | Potential Moderators: Perceived Attitudes/Expectations | Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree
My police agency values administering naloxone. My police agency values linking people who use drugs to treatment. My department does not appreciate effort from me to help people who use drugs get treatment and stay alive. My agency would ignore any complaint from me regarding officer misconduct toward people who use drugs. The agency cares that I do not get hurt by needlestick injuries. The agency is willing to extend itself in order to help me stay safe when handling needles. Helping people who are addicted to drugs is a part of determining who gets promoted in my police agency. The agency cares about my opinions about people who use drugs. The agency wishes to give me all the available resources possible for helping people who use drugs. |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Prior instances of witnessing an opioid-related overdose | The following questions relate to your experiences with opioid overdose. For each item, please choose what best describes your response to each statement (select ONLY one for each item).
Over your career, how often have you been at the scene of overdose emergencies? Over your career, how often have you administered naloxone to a civilian experiencing an overdose? Over your career, how often have you administered naloxone to a law enforcement officer experiencing an overdose? Over your career, how often have you been exposed to touching or breathing in powder fentanyl? |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Prior instances of working with syringes | The following questions cover your experiences with syringes in the line of duty. Select the one best response for each item:
In the last 3 months, how often have you transported syringes (for evidence or other reasons)? In the last 3 months, how often have you discarded syringes in the trash? In the last 3 months, how often have you confiscated syringes from an individual? In the last 3 months, how often have you confiscated naloxone/Narcan? In the last 3 months, how often have you arrested someone for syringe possession? In the last 3 months, how often have you arrested someone for drug possession? Over your entire policing career, how often have you been accidentally stuck by a needle? In the last 3 months, how often were you accidentally stuck by a needle? In the last 3 months, how often have you been at scenes of overdoses? |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Prior instances responding to an overdose | Now please tell us just about the following events which you may have experienced when responding to an overdose in the past 3 months.
When responding to ODs in the past 3 months, how often were you or your partner exposed to fentanyl class drugs? When responding to ODs in the past 3 months, how often have you informed someone about the 911 Good Samaritan Law? When responding to ODs in the past 3 months, how often have you arrested someone at the scene? When responding to ODs in the past 3 months, how often have you administered naloxone to a civilian? |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Other | Experiences with other programs | This next set of questions relate to your experiences with other programs in addressing the overdose crisis in your community:
In the last 3 months, how often have you provided information about or made referrals to drug treatment programs? In the last 3 months, how often have you made referrals to syringe service programs? In the last 3 months, how often have you made referrals to naloxone distribution programs? In the last 3 months, how often have you made referrals to social support (e.g. housing, employment) programs? |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Primary | Change in Naloxone Behavioral Outcomes in Policing Procedure | Number of days during the past 30 days in which participants had naloxone available and carried naloxone while at work. | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Primary | Change in Naloxone Behavioral Outcomes in Policing Procedure | Number of days during the past 30 days in which participants had naloxone available and carried naloxone outside of work hours. | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Primary | Change in Naloxone Behavioral Outcomes in Policing Procedure | Number of days during the past 30 days in which participants responded to an OD event, attempted to intervene, and/or administered naloxone. | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Primary | Change in Referral Behavioral Outcomes in Policing Procedure | Number of referrals to evidence-based or other drug treatment or social services made during the past 30 days. | Time frame: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Primary | Change in Confiscation Behavioral Outcomes in Policing Procedure | Number of episodes involving syringe confiscation in the past 30 days (with/without proper technique). | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Primary | Change in Confiscation Behavioral Outcomes in Policing Procedure | Number of episodes in the past 30 days involving drug confiscation (with/without proper technique). | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Change in participant knowledge about needle stick injury and treatment | Which of the following diseases is MOST likely to be transmitted by a needle stick injury? | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Change in participant knowledge about needle stick injury and treatment | The risk of getting a bloodborne infection as a result of a needle stick injury is high (check only one response). | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Change in participant knowledge about needle stick injury and treatment | To avoid being stuck with a needle, police officers should (select ALL that apply) | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Change in participant knowledge about needle stick injury and treatment | The evidentiary value of syringes and any drug residue therein is (fill in the blank by checking only one response).
5) Possession of syringes is (fill in the blank by checking only one response). 6) Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Change in participant knowledge about needle stick injury and treatment | Possession of syringes is (fill in the blank by checking only one response). 6) Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Change in participant knowledge about needle stick injury and treatment | Confiscating syringes from people who inject drugs... (check all that apply):
7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Change in participant knowledge about needle stick injury and treatment | Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Degree of participant familiarity with proper technique for dealing with contaminated injection equipment | Please indicate your agreement with the following statements relating to needle stick prevention and response (1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree):
I feel confident in my ability to avoid needlestick injuries. I feel confident in my ability to get people who inject drugs to tell me if they have sharps before I search them. I feel confident in my ability to conduct a Terry Stop with minimal risk of a needlestick injury. In the event of needle stick injury, I would know the response protocol. In the event of a needle stick injury, I feel confident in my ability to get the right testing and medical care. In the event of a needle stick injury, I feel comfortable talking to the owner of the needle about coming with me to get tested. |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Degree of participant awareness of post-exposure prophylaxis (PEP) and its uses | (1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree):
A first responder's risk of experiencing an overdose from touching fentanyl is high (select one response) A first responder's risk of experiencing an overdose from breathing fentanyl is high (select one response) Possession of naloxone by civilians is authorized only when accompanied with a valid prescription (select one response) The 911 Good Samaritan Law... (fill in the blank and select all that apply) When called to an overdose scene, it is best practice for police officers to... (fill in the blank and select all that apply) |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] | |
Secondary | Degree of participant awareness of risk of fentanyl exposure and proper technique for dealing with synthetic opioids | Response options: (1 = all the time, 2 = most of the time, 3 = sometimes, 4 = rarely, 5 = never):
I am confident that I won't overdose from incidental skin contact with fentanyl. I am confident about my ability to use basic protective equipment to avoid fentanyl exposure. I am confident that I can recognize an opioid overdose when I see it. I am confident that I can effectively reverse an overdose using rescue techniques and naloxone. I am confident that I know how to conduct myself at an overdose scene to safeguard public health and public safety. |
[Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04372238 -
The Rhode Island Prescription and Illicit Drug Study
|
N/A | |
Recruiting |
NCT03924505 -
Preventing Opioid Overdose Mortality in the United States
|
N/A | |
Completed |
NCT05093309 -
Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone
|
N/A | |
Completed |
NCT05219669 -
Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens
|
Phase 1 | |
Completed |
NCT04317053 -
Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program
|
Phase 3 | |
Not yet recruiting |
NCT06466005 -
UnityPhilly Response App for Overdose Reversal
|
||
Recruiting |
NCT04815590 -
Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose
|
||
Active, not recruiting |
NCT05096429 -
Preventing Overdose Using Information and Data From the Environment
|
N/A | |
Suspended |
NCT05114460 -
Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal
|
Phase 2 | |
Recruiting |
NCT06238128 -
Opioid Rapid Response System: Naloxone Training in Communities
|
N/A | |
Completed |
NCT02662153 -
Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics
|
||
Active, not recruiting |
NCT05944133 -
Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
|
||
Completed |
NCT05377255 -
Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
|
Phase 1 | |
Recruiting |
NCT05877118 -
Improving Availability of Intranasal Naloxone
|
N/A | |
Recruiting |
NCT05072249 -
European Cohort Study of the Effectiveness of Take Home Naloxone
|
||
Withdrawn |
NCT05808881 -
Clinical Outcomes From Nalmefene
|
Phase 4 | |
Not yet recruiting |
NCT01622504 -
Naloxone Nasal Spray Pharmacokinetic Study
|
Phase 1 | |
Not yet recruiting |
NCT06429436 -
Vending Machine Naloxone Distribution for Your Community (VENDY)
|
Phase 4 | |
Completed |
NCT05506267 -
Development of a Tracheal Sound Sensor
|
||
Completed |
NCT02535494 -
Risks and Benefits of Naloxone Prescribing
|
N/A |